首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Metformin HCl and Repaglinide in Pharmaceutical Formulation
【24h】

Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of Metformin HCl and Repaglinide in Pharmaceutical Formulation

机译:紫外分光光度法同时估算药物制剂中盐酸二甲双胍和瑞格列奈的研制与验证

获取原文
           

摘要

Objective: A new, simple, rapid, accurate and economical method have been developed for the simultaneous estimation of Metformin HCl and Repaglinide in formulation. Method: The absorbances of both the drugs were determined at 238 nm and at 294 nm. The linearity was observed in the concentration range of 2-100 μg/ml and 1-35 μg/ml for Metformin HCl and Repaglinide respectively. The method was validated as per ICH guidelines. Result: The recovery of Metformin and Repaglinide was found in the range of 98.24 ± 0.325 to 100.25 ± 0.756. Conclusion: The proposed method was accurate, reproducible and economical and can be used successfully for quantitative estimation of Metformin HCl and Repaglinide in bulk and tablet dosage form.
机译:目的:开发了一种新的,简单,快速,准确和经济的方法,用于同时估算制剂中的盐酸二甲双胍和瑞格列奈。方法:测定两种药物在238 nm和294 nm的吸光度。盐酸二甲双胍和瑞格列奈分别在2-100μg/ ml和1-35μg/ ml的浓度范围内观察到线性。该方法已按照ICH指南进行了验证。结果:二甲双胍和瑞格列奈的回收率在98.24±0.325至100.25±0.756之间。结论:该方法准确,重现,经济,可成功用于定量测定散装和片剂剂型中的盐酸二甲双胍和瑞格列奈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号